Abstract:Abstract Digital analysis of pathology whole-slide images is fast becoming a game changer in cancer diagnosis and treatment. Specifically, deep learning methods have shown great potential to support pathology analysis, with recent studies identifying molecular traits that were not previously recognized in pathology H&E whole-slide images. Simultaneous to these developments, it is becoming increasingly evident that tumor heterogeneity is an important determinant of cancer prognosis and susceptibility to treatment, and should therefore play a role in the evolving practices of matching treatment protocols to patients. State of the art diagnostic procedures, however, do not provide automated methods for characterizing and/or quantifying tumor heterogeneity, certainly not in a spatial context. Further, existing methods for analyzing pathology whole-slide images from bulk measurements require many training samples and complex pipelines. Our work addresses these two challenges. First, we train deep learning models to spatially resolve bulk mRNA and miRNA expression levels on pathology whole-slide images (WSIs). Our models reach up to 0.95 AUC on held-out test sets from two cancer cohorts using a simple training pipeline and a small number of training samples. Using the inferred gene expression levels, we further develop a method to spatially characterize tumor heterogeneity. Specifically, we produce tumor molecular cartographies and heterogeneity maps of WSIs and formulate a heterogeneity index (HTI) that quantifies the level of heterogeneity within these maps. Applying our methods to breast and lung cancer slides, we show a significant statistical link between heterogeneity and survival. Our methods potentially open a new and accessible approach to investigating tumor heterogeneity and other spatial molecular properties and their link to clinical characteristics, including treatment susceptibility and survival.

The 3D Revolution in Cancer Discovery

Regulation of 3D Organization and Its Role in Cancer Biology

3C methods in cancer research: recent advances and future prospects

Application of 3D/4D/5D and 6D Bioprinting in Cancer Research: How Does the Future Look Like?

Application and progress of 3D tumor models in breast cancer

The spatial multi-omics revolution in cancer therapy: Precision redefined

3D Genomic Organization in Cancers

Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer

Spatial omics: Navigating to the golden era of cancer research

Tracing the evolution of single-cell cancer 3D genomes: an atlas for cancer gene discovery

A comprehensive review of 3D cancer models for drug screening and translational research

Advances in spatial multi-omics in tumors

Three-dimensional computer vision for exploring heterogeneity in collective Cancer Invasion

Transcending toward Advanced 3D-Cell Culture Modalities: A Review about an Emerging Paradigm in Translational Oncology

Application of 3D printing technology in tumor diagnosis and treatment

Applicability of Spatial Technology in Cancer Research

Three-Dimensional (3D) Printing in Cancer Therapy and Diagnostics: Current Status and Future Perspectives

Spatial omics techniques and data analysis for cancer immunotherapy applications

Three-dimensional bio-printing: A new frontier in oncology research

Application of Three-Dimensional Cell Culture Model in Cancer Research

Abstract 1710: Spatial transcriptomics and multiplexed imaging to explore tumor heterogeneity and immune complexity